Alaranta Antti, Alaranta Hannu, Helenius Ilkka
Nutrimed Ltd, Helsinki, Finland.
Sports Med. 2008;38(6):449-63. doi: 10.2165/00007256-200838060-00002.
Although athletes are young and generally healthy, they use a variety of non-doping classified medicines to treat injuries, cure illnesses and obtain a competitive edge. Athletes and sports medicine physicians try to optimize the treatment of symptoms related to extreme training during an elite athlete's active career. According to several studies, the use of antiasthmatic medication is more frequent among elite athletes than in the general population. The type of training and the kind of sport influence the prevalence of asthma. Asthma is most common among those competing in endurance events, such as cycling, swimming, cross-country skiing and long-distance running. Recent studies show that athletes use also NSAIDs and oral antibacterials more commonly than age-matched controls, especially athletes competing in speed and power sports. Inappropriately high doses and concomitant use of several different NSAIDs has been observed. All medicines have adverse effects that may have deleterious effects on elite athletes' performance. Thus, any unnecessary medication use should be minimized in elite athletes. Inhaled beta(2)-agonists may cause tachycardia and muscle tremor, which are especially harmful in events requiring accuracy and a steady hand. In experimental animal models of acute injury, especially selective cyclo-oxygenase-2 inhibitors have been shown to be detrimental to tissue-level repair. They have been shown to impair mechanical strength return following acute injury to bone, ligament and tendon. This may have clinical implications for future injury susceptibility. However, it should be noted that the current animal studies have limited translation to the clinical setting. Adverse effects related to the CNS and gastrointestinal adverse reactions are commonly reported in connection with NSAID use also in elite athletes. In addition to the potential for adverse effects, recent studies have shown that NSAID use may negatively regulate muscle growth by inhibiting protein synthesis. Physicians and pharmacists taking care of athletes' medication need to be aware of the medicines that an athlete is taking and how those medicines interact with performance, exercise, environment and other medicines. Sport associations should repeatedly monitor not only the use of banned substances, but also the trends of use of legal medicines in athletes. Not only physicians and pharmacists, but also athletes and coaches should be better educated with respect to potential benefits and risks, and how each agent may affect an athlete's performance. The attitudes and beliefs leading to ample use of legal medicines in athletes is an interesting area of future research.
尽管运动员年轻且总体健康,但他们会使用各种未被列为兴奋剂的药物来治疗伤痛、治愈疾病并获取竞争优势。运动员和运动医学医生试图在精英运动员的活跃职业生涯中优化与极限训练相关症状的治疗。根据多项研究,精英运动员中使用抗哮喘药物的频率高于普通人群。训练类型和运动项目会影响哮喘的患病率。哮喘在参加耐力项目的运动员中最为常见,如自行车、游泳、越野滑雪和长跑。最近的研究表明,与年龄匹配的对照组相比,运动员使用非甾体抗炎药(NSAIDs)和口服抗菌药物的情况也更为普遍,尤其是参加速度和力量型运动的运动员。已观察到存在不适当的高剂量使用以及同时使用几种不同NSAIDs的情况。所有药物都有不良反应,可能会对精英运动员的表现产生有害影响。因此,应尽量减少精英运动员不必要的药物使用。吸入型β₂激动剂可能会导致心动过速和肌肉震颤,这在需要精准度和稳定手部的项目中尤其有害。在急性损伤的实验动物模型中,特别是选择性环氧化酶-2抑制剂已被证明对组织水平的修复有害。它们已被证明会损害骨骼、韧带和肌腱急性损伤后机械强度的恢复。这可能对未来的受伤易感性有临床意义。然而,应注意的是,目前的动物研究在临床应用中的转化有限。与NSAIDs使用相关的中枢神经系统不良反应和胃肠道不良反应在精英运动员中也经常被报告。除了潜在的不良反应外,最近的研究表明,NSAIDs的使用可能通过抑制蛋白质合成对肌肉生长产生负面调节作用。负责运动员用药的医生和药剂师需要了解运动员正在服用的药物以及这些药物如何与表现、运动、环境和其他药物相互作用。体育协会不仅应反复监测违禁物质的使用情况,还应监测运动员使用合法药物的趋势。不仅医生和药剂师,运动员和教练也应更好地了解潜在的益处和风险,以及每种药物可能如何影响运动员的表现。导致运动员大量使用合法药物的态度和观念是未来研究的一个有趣领域。